| Dr Jeffrey Charles Thompson, MD | |
|
33355 Health Campus Blvd, Avon, OH 44011-1399 | |
| (440) 937-9099 | |
| (440) 937-9755 |
| Full Name | Dr Jeffrey Charles Thompson |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 14 Years |
| Location | 33355 Health Campus Blvd, Avon, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427378272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD452416 (Pennsylvania) | Primary |
| 208100000X | Physical Medicine & Rehabilitation | 35.129461 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospitals Ahuja Medical Center | Beachwood, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
Protalix Biotherapeutics, Inc. today announced the completion of its New Drug Application (NDA) submission with the U.S. Food and Drug Administration (FDA) for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) for the potential treatment of Gaucher's disease.
Inflammation drives the progression of neurodegenerative brain diseases and plays a major role in the accumulation of tau proteins within neurons.
Parkinson's experts across the world have been reporting a remarkable phenomenon - many patients treated with drugs to increase the activity of dopamine in the brain as a therapy for motor symptoms such as tremors and muscle rigidity are developing new creative talents, including painting, sculpting, writing, and more.
A "metal foam" that has a similar elasticity to bone could mean a new generation of biomedical implants that would avoid bone rejection that often results from more rigid implant materials, such as titanium.
› Verified 9 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
Protalix Biotherapeutics, Inc. today announced the completion of its New Drug Application (NDA) submission with the U.S. Food and Drug Administration (FDA) for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) for the potential treatment of Gaucher's disease.
Inflammation drives the progression of neurodegenerative brain diseases and plays a major role in the accumulation of tau proteins within neurons.
Parkinson's experts across the world have been reporting a remarkable phenomenon - many patients treated with drugs to increase the activity of dopamine in the brain as a therapy for motor symptoms such as tremors and muscle rigidity are developing new creative talents, including painting, sculpting, writing, and more.
A "metal foam" that has a similar elasticity to bone could mean a new generation of biomedical implants that would avoid bone rejection that often results from more rigid implant materials, such as titanium.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Charles Thompson, MD 33355 Health Campus Blvd, Avon, OH 44011-1399 Ph: (440) 937-9099 | Dr Jeffrey Charles Thompson, MD 33355 Health Campus Blvd, Avon, OH 44011-1399 Ph: (440) 937-9099 |
News Archive
Protalix Biotherapeutics, Inc. today announced the completion of its New Drug Application (NDA) submission with the U.S. Food and Drug Administration (FDA) for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) for the potential treatment of Gaucher's disease.
Inflammation drives the progression of neurodegenerative brain diseases and plays a major role in the accumulation of tau proteins within neurons.
Parkinson's experts across the world have been reporting a remarkable phenomenon - many patients treated with drugs to increase the activity of dopamine in the brain as a therapy for motor symptoms such as tremors and muscle rigidity are developing new creative talents, including painting, sculpting, writing, and more.
A "metal foam" that has a similar elasticity to bone could mean a new generation of biomedical implants that would avoid bone rejection that often results from more rigid implant materials, such as titanium.
› Verified 9 days ago
Saman Ghaffari, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 877-749-7428 Fax: 512-628-3314 | |
Katelyn Connelly, OTR/L, OTD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 35755 Detroit Rd, Avon, OH 44011 Phone: 440-937-3111 | |
Dr. Sonya Marie Kuhar, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 877-749-7428 Fax: 512-628-3314 | |
Nicholee Stamm, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 33200 Health Campus Blvd, Avon, OH 44011 Phone: 440-517-2050 |